Haploid Cell SMN1 Screening for Silent SMA Carrier Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting silent carriers of spinal muscular atrophy (SMA) are challenging due to the high homology between the SMN1 and SMN2 genes, making it difficult to identify individuals with a 2+0 genotype using conventional gene dosage analysis, and linkage analysis is complicated by the large distance between these genes on the same chromosome.
Innovation Solution
The method involves analyzing haploid cells, such as sperm or egg cells, through nucleic acid amplification reactions using specific primers for the SMN1 gene and a reference gene, and determining the ratio of amplification products to identify silent carriers by comparing the presence or absence of the SMN1 gene relative to the reference gene, with a threshold ratio indicating carrier status.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional gene dosage analysis is used to detect SMN1 deletion, then carrier status can be determined for heterozygous individuals, but silent carrier genotypes (2+0) cannot be detected
Solution Approach 1:
The invention segments the detection process into two independent components: (1) gene dosage analysis to determine total SMN1 copy number, and (2) haplotype analysis to determine chromosomal arrangement. By separating these functions, the method can detect both heterozygous carriers (1+1) and silent carriers (2+0), resolving the limitation of conventional single-method approaches
Solution Approach 2:
The invention introduces haplotype analysis as an intermediary method that bridges the gap left by gene dosage analysis. While gene dosage provides quantitative information about SMN1 copies, haplotype analysis provides qualitative information about their chromosomal arrangement, together enabling comprehensive carrier detection
2Measurement precision
If allele-specific assays are designed to detect SMN1 abnormalities, then detection specificity improves, but assay design complexity increases due to high homology with SMN2
Solution Approach 1:
Instead of attempting to detect all possible SMN1/SMN2 variations with a single complex assay, the invention uses partial action by focusing on specific informative markers (exon 7 for SMN1, exon 8 for SMN2) that provide sufficient discrimination. This selective approach maintains high specificity while reducing assay complexity compared to comprehensive sequencing methods
3Reliability
If linkage analysis is performed to detect chromosomal alterations, then silent carrier detection may be possible, but the large distance (800 kb) between SMN1 and SMN2 genes makes linkage analysis difficult
Solution Approach 1:
The invention extracts and analyzes specific haplotype markers (exon 7 of SMN1 and exon 8 of SMN2) that are physically close to each other on the chromosome. By focusing on these closely-spaced markers rather than attempting genome-wide linkage analysis across the 800 kb distance, the method achieves silent carrier detection through haplotype phase determination while avoiding the difficulties of long-range linkage analysis
Data Source
AI summary
Provided herein are methods and compositions for the detection of silent carriers of chromosomal deletion alleles in a human subject using haploid cells (e.g., sperm cells or egg cells) derived from the subject. The methods provided herein allow for the detection of silent (2+0) carriers of SMA, where the individual has a deletion of the SMN1 gene on one chromosome 5 homolog and two or more copies of the SMN1 gene on the other chromosome 5 homolog.